Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...

Eydenzelt is a vascular endothelial growth factor inhibitor referencing Eylea, which is jointly developed by Regeneron ...

Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., will be featuring LACRIFILL Canalicular Gel, a novel therapy for dry eye symptoms, at the American Academy of Ophthalmology Annual Meeting in ...

Elderly people living on the Sunshine Coast who need eye injections in order to maintain their sight are having to pay out of ...

US FDA approves Celltrion’s Eydenzelt biosimilar referencing Eylea to treat wAMD, macular edema following RVO, DME and diabetic retinopathy: Incheon, South Korea Monday, October ...

Celltrion said Friday that its eye disease treatment Eydenzelt won approval from the U.S. Food and Drug Administration (FDA), ...

Early and aggressive treatment of dry eye disease can prevent progression and preserve ocular health, especially in glaucoma ...

Visara is launching with $37 million from I-Mab and will be led by Emmett Cunningham Jr., M.D., Ph.D., an ophthalmologist and ...

South Korea-based Celltrion on Friday announced that the US Food and Drug Administration (FDA) has approved Eydenzelt ...

This is a developing news story. Please check back soon for updates. The FDA approved Eydenzelt, a biosimilar referencing ...

Celltrion’s biosimilar, Eydenzelt (aflibercept-boav), has been approved by the FDA as a treatment for adult patients with neovascular (wet) age-related macular degeneration (wAMD), macular edema ...

Blurred vision can be a sign of a brain stroke. A 34-year-old man's persistent visual blurring was initially missed by eye ...